switch maintenance therapy Latest Research Papers

Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study

Investigational New Drugs ◽

10.1007/s10637-020-01015-z ◽

2020 ◽

Author(s):

Jie Liu ◽

Yao-Tiao Deng ◽

Yu Jiang

Keyword(s):

Retrospective Study ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Maintenance Therapy ◽

Single Center ◽

Metastatic Soft Tissue Sarcoma ◽

Switch Maintenance Therapy

Download Full-text

Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2020.100202 ◽

2020 ◽

Vol 24 ◽

pp. 100202

Author(s):

Neal S. Chawla ◽

Jasnoor Malhotra ◽

Sumanta K. Pal

Keyword(s):

Bladder Cancer ◽

Maintenance Therapy ◽

Paradigm Shift ◽

Advanced Bladder Cancer ◽

Switch Maintenance Therapy

Download Full-text

P2.01-33 Survival Benefit of Depleting High Serum EGF Concentration in Advanced NSCLC Patients as Switch Maintenance Therapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1377 ◽

2019 ◽

Vol 14 (10) ◽

pp. S651-S652

Author(s):

O. Santos Morales ◽

E. Neninger ◽

R. Carrodeguas ◽

P. Luaces ◽

P. Rodríguez ◽

...

Keyword(s):

Maintenance Therapy ◽

Survival Benefit ◽

Advanced Nsclc ◽

High Serum ◽

Nsclc Patients ◽

Switch Maintenance Therapy

Download Full-text

Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

Investigational New Drugs ◽

10.1007/s10637-019-00747-x ◽

2019 ◽

Vol 37 (3) ◽

pp. 531-537 ◽

Cited By ~ 1

Author(s):

Norimichi Akiyama ◽

Masato Karayama ◽

Naoki Inui ◽

Hideki Yasui ◽

Hironao Hozumi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Maintenance Therapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Induction Therapy ◽

Lung Squamous Cell Carcinoma ◽

Switch Maintenance Therapy

Download Full-text

Oral Vinorelbine as Switch Maintenance Therapy versus Best Supportive Care in Patients with Advanced Adenocarcinoma Non-Small Cell Lung Cancer EGFR Wild Type

Journal of Cancer Therapy ◽

10.4236/jct.2019.1012077 ◽

2019 ◽

Vol 10 (12) ◽

pp. 908-914

Author(s):

Amen Hamdy Zaky ◽

Ahmed Refaat Abd Elzaher ◽

Ola Nabih

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Supportive Care ◽

Small Cell Lung Cancer ◽

Best Supportive Care ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Switch Maintenance Therapy

Download Full-text

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

BMC Cancer ◽

10.1186/s12885-018-4556-6 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 3

Author(s):

Kenichi Inoue ◽

Jun Ninomiya ◽

Tsuyoshi Saito ◽

Kei Kimizuka ◽

Masafumi Kurosumi

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Study ◽

Maintenance Therapy ◽

Metastatic Breast ◽

Japanese Patients ◽

Open Label ◽

Open Label Phase ◽

Phase Ii Clinical Study ◽

Switch Maintenance Therapy

Download Full-text

Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study

Medical Oncology ◽

10.1007/s12032-018-1172-x ◽

2018 ◽

Vol 35 (7) ◽

Cited By ~ 1

Author(s):

Koji Nishimoto ◽

Masato Karayama ◽

Naoki Inui ◽

Hideki Yasui ◽

Hironao Hozumi ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Induction Therapy ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Switch Maintenance Therapy

Download Full-text

A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma

Annals of Oncology ◽

10.1093/annonc/mdx440.035 ◽

2017 ◽

Vol 28 ◽

pp. v626 ◽

Cited By ~ 6

Author(s):

J. Ledermann ◽

J. Sehouli ◽

B. Zurawski ◽

F. Raspagliesi ◽

U. De Giorgi ◽

...

Keyword(s):

Maintenance Therapy ◽

Ovarian Carcinoma ◽

Epithelial Ovarian Carcinoma ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Switch Maintenance Therapy ◽

Randomized Phase 2

Download Full-text

Switch maintenance therapy with racotumomab or nimotuzumab vs docetaxel for NSCLC patients

Annals of Oncology ◽

10.1093/annonc/mdw378.47 ◽

2016 ◽

Vol 27 ◽

pp. vi374

Author(s):

M. Hernandez ◽

E. Neninger ◽

R.A. Ortiz ◽

K. Camacho ◽

R.M. Amador ◽

...

Keyword(s):

Maintenance Therapy ◽

Nsclc Patients ◽

Switch Maintenance Therapy

Download Full-text

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)

The Prostate ◽

10.1002/pros.23236 ◽

2016 ◽

Vol 76 (16) ◽

pp. 1519-1527 ◽

Cited By ~ 8

Author(s):

Richard Cathomas ◽

Simon J. Crabb ◽

Michael Mark ◽

Ralph Winterhalder ◽

Christian Rothermundt ◽

...

Keyword(s):

Prostate Cancer ◽

Maintenance Therapy ◽

Controlled Trial ◽

Castration Resistant Prostate Cancer ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Castration Resistant ◽

Switch Maintenance Therapy

Download Full-text

switch maintenance therapy
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study

Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020

P2.01-33 Survival Benefit of Depleting High Serum EGF Concentration in Advanced NSCLC Patients as Switch Maintenance Therapy

Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

Oral Vinorelbine as Switch Maintenance Therapy versus Best Supportive Care in Patients with Advanced Adenocarcinoma Non-Small Cell Lung Cancer EGFR Wild Type

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study

A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma

Switch maintenance therapy with racotumomab or nimotuzumab vs docetaxel for NSCLC patients

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)

Export Citation Format

switch maintenance therapyRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective study

Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020

P2.01-33 Survival Benefit of Depleting High Serum EGF Concentration in Advanced NSCLC Patients as Switch Maintenance Therapy

Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

Oral Vinorelbine as Switch Maintenance Therapy versus Best Supportive Care in Patients with Advanced Adenocarcinoma Non-Small Cell Lung Cancer EGFR Wild Type

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study

A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma

Switch maintenance therapy with racotumomab or nimotuzumab vs docetaxel for NSCLC patients

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)

switch maintenance therapy
Recently Published Documents